Correcting mitochondrial dynamics, metabolic control of pathogenic or therapeutic cells emerge among translational innovations in BioCentury’s survey of 2023 publications

BioCentury is providing this story for free given the urgent need for information about the COVID-19 crisis. For more analysis, sign up for our daily email.

ASH abstracts reveal new mechanisms and consequences of immune cell repolarization in hematology

Pharmacodynamic biomarkers are driving IO combos in absence of monotherapy responses